Shopping Cart
- Remove All
Your shopping cart is currently empty
HBX is a deubiquitinase inhibitor. It inhibits HAdV type 5 (species C, HAdV-C5) replication and oncogenic transformation through inhibition of the cellular pro-viral factor ubiquitin-specific protease 7 (USP7). HBX also significantly inhibits virus genome replication and progeny release of all adenovirus types tested, with the exception of types 12 and 31, from tested species.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $143 | 6-8 weeks | |
| 50 mg | $214 | 6-8 weeks | |
| 100 mg | $357 | 6-8 weeks |
| Description | HBX is a deubiquitinase inhibitor. It inhibits HAdV type 5 (species C, HAdV-C5) replication and oncogenic transformation through inhibition of the cellular pro-viral factor ubiquitin-specific protease 7 (USP7). HBX also significantly inhibits virus genome replication and progeny release of all adenovirus types tested, with the exception of types 12 and 31, from tested species. |
| Molecular Weight | 232.2 |
| Formula | C13H4N4O |
| Cas No. | 40114-84-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.